Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01773681 · ClinicalTrials.gov registry record

Novel Imaging Markers for Rheumatoid Arthritis

A clinical trial, sponsored by University of California, San Francisco.

Completed
Registry status
30
Enrollment target

NCT01773681: Completed study, sponsored by University of California, San Francisco.

NCT01773681 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01773681 has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
30 participants
Enrollment target

Study Summary

The purpose of this study is to use magnetic resonance imaging (MRI) and high-resolution peripheral quantitative computed tomography (HR-pQCT) techniques to look at the damage and disease activity progression in the hand and wrist joints of patients with rheumatoid arthritis. The central hypothesis is that ongoing erosions and cartilage loss in rheumatoid arthritis are due to persistent inflammation, which is poorly detected by clinical examination and markers of systemic inflammation.

Interventions

  • DEVICE Magnetic Resonance Imaging (MRI)
  • DRUG Cimzia
  • DEVICE High-resolution peripheral quantitative computed tomography (HR-pQCT)

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2013-10
Est. Completion 2018-03

What the finished NCT01773681 record still lists

NCT01773681 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.

The record links to 0 conditions, and to 3 interventions - of which Magnetic Resonance Imaging (MRI) is the first listed.

NCT01773681 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01773681 about?

NCT01773681 is a clinical study titled "Novel Imaging Markers for Rheumatoid Arthritis". The purpose of this study is to use magnetic resonance imaging (MRI) and high-resolution peripheral quantitative computed tomography (HR-pQCT) techniques to look at the damage and disease activity progression in the hand and wrist joints of patients with rheumatoid arthritis. The central hypothesis...

What is the current status of trial NCT01773681?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2013-10. Estimated completion is 2018-03.

What interventions are being tested in trial NCT01773681?

The interventions under investigation include: Magnetic Resonance Imaging (MRI) (DEVICE), Cimzia (DRUG), High-resolution peripheral quantitative computed tomography (HR-pQCT) (DEVICE).

Who is sponsoring clinical trial NCT01773681?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01773681, the US trial registry maintained by the National Library of Medicine. NCT01773681 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.